The Novelty of Icosapent Ethyl in the Management of Hypertriglyceridemia and Alleviating Cardiovascular Risk

The Novelty of Icosapent Ethyl in the Management of Hypertriglyceridemia and Alleviating Cardiovascular Risk

Hypertriglyceridemia is believed to be independently associated with an elevated risk of cardiovascular disease (CVD) events. Lifestyle changes and dietary modifications are recommended for individuals with high serum triglyceride (TG) levels (150-499 mg/dl), and pharmacological therapy in addition...

Full description

Bibliographic Details
Main Authors:	Muhammad Shoaib Khan, Muhammad Ishaq, Muhammad Talha Ayub, Ateeq U. Rehman, John J. Hayes, Mohammad Mortada, Robert W. W. Biederman
Format:	Article
Language:	English
Published:	Hindawi Limited 2021-01-01
Series:	Journal of Lipids
Online Access:	http://dx.doi.org/10.1155/2021/6696915

Similar Items

Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia
by: M Aseem Basha
Published: (2019-01-01)

Icosapent ethyl for the treatment of severe hypertriglyceridemia
by: Fares H, et al.
Published: (2014-06-01)

Reduction of Revascularizations in Patients with Hypertriglyceridemia with Icosapent Ethyl: Insights from REDUCE-IT REVASC
by: Benjamin E. Peterson, M.D, et al.
Published: (2020-09-01)

Spotlight on Icosapent Ethyl for Cardiovascular Risk Reduction: Evidence to Date
by: Jia X, et al.
Published: (2020-01-01)

Icosapent ethyl: scientific and legal controversies
by: Gregory Curfman, et al.
Published: (2021-06-01)

Icosapent ethyl: safely reducing cardiovascular risk in adults with elevated triglycerides
by: Bhatt, D.L, et al.
Published: (2022)

Prevention of Cardiovascular Events and Mortality With Icosapent Ethyl in Patients With Prior Myocardial Infarction
by: Ballantyne, C.M, et al.
Published: (2022)

Potential Benefits of Icosapent Ethyl on the Lipid Profile: Case Studies
by: Daniel E. Hilleman, et al.
Published: (2014-02-01)

Potential Benefits of Icosapent Ethyl on the Lipid Profile: Case Studies
by: Daniel E. Hilleman, et al.
Published: (2014-01-01)

A randomized trial of icosapent ethyl in ambulatory patients with COVID-19
by: Andrew Kosmopoulos, et al.
Published: (2021-09-01)

Lowering triglycerides to modify cardiovascular risk: will icosapent deliver?
by: Scherer DJ, et al.
Published: (2015-03-01)

Treatment With Icosapent Ethyl to Reduce Ischemic Events in Patients With Prior Percutaneous Coronary Intervention: Insights From REDUCE-IT PCI
by: Ballantyne, C.M, et al.
Published: (2022)

Parvimonasmicra bacteremia in a patient with colonic carcinoma
by: Muhammad Shoaib Khan, et al.
Published: (2019-09-01)

Switching from EPA + DHA (Omega-3-acid Ethyl Esters) to High-Purity EPA (Icosapent Ethyl) in a Statin-Treated Patient with Persistent Dyslipidemia and High Cardiovascular Risk: A Case Study
by: James R. Crandell
Published: (2016-01-01)

Switching from EPA + DHA (Omega-3-acid Ethyl Esters) to High-Purity EPA (Icosapent Ethyl) in a Statin-Treated Patient with Persistent Dyslipidemia and High Cardiovascular Risk: A Case Study
by: James R. Crandell
Published: (2016-07-01)

Icosapent Ethyl Effects on Fatty Acid Profiles in Statin-Treated Patients With High Triglycerides: The Randomized, Placebo-controlled ANCHOR Study
by: Christie M. Ballantyne, et al.
Published: (2019-02-01)

Concurrent arterial and venous thrombosis in a patient with catastrophic antiphospholipid syndrome
by: Muhammad Shoaib Khan, et al.
Published: (2021-07-01)

Coronary Microvascular Dysfunction and the Role of Noninvasive Cardiovascular Imaging
by: Muhammad Talha Ayub, et al.
Published: (2020-09-01)

Targeting hypertriglyceridemia to mitigate cardiovascular risk: A review
by: Peter P. Toth, et al.
Published: (2020-09-01)

Dynamic cardiac anatomy: the "cypress tree" papillary muscle root
by: Muhammad Shoaib Khan, et al.
Published: (2018-09-01)

Hypertriglyceridemia
by: Amanda Brahm, et al.
Published: (2013-03-01)

Understanding hypertriglyceridemia in women: clinical impact and management with prescription omega-3-acid ethyl esters
by: Thomas D Dayspring
Published: (2011-03-01)

Alterations in serum phosphatidylcholine fatty acyl species by eicosapentaenoic and docosahexaenoic ethyl esters in patients with severe hypertriglyceridemia
by: B J McKeone, et al.
Published: (1997-03-01)

Genetics of Hypertriglyceridemia
by: Jacqueline S. Dron, et al.
Published: (2020-07-01)

Hypertriglyceridemia and atherosclerosis
by: Jia Peng, et al.
Published: (2017-12-01)

Hypertriglyceridemia and cardiovascular risk: a cautionary note about metabolic confounding
by: Allan D. Sniderman, et al.
Published: (2018-01-01)

Fatal Hypermagnesemia: an acute ingestion of Epsom Salt in a patient with normal renal function
by: Muhammad Shoaib Khan, et al.
Published: (2018-09-01)

Inflammatory Cardiovascular Risk Biomarkers: Update on Novelties and Limitations
by: Fabrizio Montecucco, et al.
Published: (2012-01-01)

Abnormal bile acid absorption in familial hypertriglyceridemia
by: W C Duane
Published: (1995-01-01)

Familial hypertriglyceridemia: an entity with distinguishable features from other causes of hypertriglyceridemia
by: Ivette Cruz-Bautista, et al.
Published: (2021-02-01)

The Experience of Novelty and the Novelty of Experience
by: Liubov Skavronskaya, et al.
Published: (2020-02-01)

The association of hypertriglyceridemia with cardiovascular events and pancreatitis: a systematic review and meta-analysis
by: Murad M Hassan, et al.
Published: (2012-03-01)

Causes and Consequences of Hypertriglyceridemia
by: Chris J. Packard, et al.
Published: (2020-05-01)

Treatment of patients with hypertriglyceridemia
by: Tat'yana Alekseevna Rozhkova, et al.
Published: (2009-09-01)

Precoding in MIMO, OFDM to reduce PAPR (Peak to Average Power Ratio)
by: Ishaq, Muhammad Irfan, et al.
Published: (2012)

Methyl 2-ethyl-4-hydroxy-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide
by: Muhammad Nadeem Arshad, et al.
Published: (2010-05-01)

Spinal epidural abscess due to Pasteurella multocida infection
by: Fahad Aftab Khan Lodhi, et al.
Published: (2020-01-01)

Clozapine-induced acute hypertriglyceridemia
by: Mitesh Kumar, et al.
Published: (2017-01-01)

Hypertriglyceridemia: etiology, pathogenesis, diagnostics
by: T. V. Chepetova, et al.
Published: (2006-10-01)

Managing Hypertriglyceridemia in Daily Practice
by: Laurentius A Pramono, et al.
Published: (2015-07-01)

Cannot write session to /tmp/vufind_sessions/sess_t6fi9soq6noaq5pkb0mstnr9jj